Cargando…

Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patients

PURPOSE: After a decade of PET/MR, the case of attenuation correction (AC) remains open. The initial four-compartment (air, water, fat, soft tissue) Dixon-based AC scheme has since been expanded with several features, the latest being MR field-of-view extension and a bone atlas. As this potentially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bogdanovic, Borjana, Gafita, Andrei, Schachoff, Sylvia, Eiber, Matthias, Cabello, Jorge, Weber, Wolfgang A., Nekolla, Stephan G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835314/ https://www.ncbi.nlm.nih.gov/pubmed/32725538 http://dx.doi.org/10.1007/s00259-020-04957-x

Ejemplares similares

The added value of PSMA PET/MR radiomics for prostate cancer staging
por: Solari, Esteban Lucas, et al.
Publicado: (2021)

Is there more than meets the eye in PSMA imaging in prostate cancer with PET/MRI? Looking closer at uptake time, correlation with PSA and Gleason score
por: Bogdanovic, Borjana, et al.
Publicado: (2023)

Value of PET ECG gating in a cross-validation study of cardiac function assessment by PET/MR imaging
por: Villagran Asiares, Alberto, et al.
Publicado: (2022)

Whole-body uptake classification and prostate cancer staging in (68)Ga-PSMA-11 PET/CT using dual-tracer learning
por: Capobianco, Nicolò, et al.
Publicado: (2021)

MR-based attenuation correction in brain PET based on UTE sequences
por: Cabello, Jorge, et al.
Publicado: (2014)

Evaluation of SUV normalized by lean body mass (SUL) in (68)Ga-PSMA11 PET/CT: a bi-centric analysis
por: Gafita, Andrei, et al.
Publicado: (2019)

Pre-test (68)Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model
por: Kraft, Pia, et al.
Publicado: (2020)

The value of (68)Ga-PSMA enhanced PET-CT and MR-PET in patients with biochemical recurrent prostate cancer
por: Rummeny, E, et al.
Publicado: (2015)

Measuring the expansion of myocardial extracellular volume using quantitative perfusion imaging: Validation with T1 mapping and simultaneous (18)FDG-PET in patients after acute myocardial infarction
por: Kunze, Karl P, et al.
Publicado: (2015)

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
por: Gafita, Andrei, et al.
Publicado: (2022)

Pitfalls in PSMA imaging: [(18)F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma
por: Feuerecker, B., et al.
Publicado: (2021)

Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with (177)Lu-PSMA I&T therapy
por: Xue, Song, et al.
Publicado: (2022)

Risks and Safety Aspects of MR-PET
por: Brix, Gunnar, et al.
Publicado: (2013)

Preclinical biodistribution and dosimetry and human biodistribution comparing (18)F-rhPSMA-7 and single isomer (18)F-rhPSMA-7.3
por: Knorr, Karina, et al.
Publicado: (2022)

10 years of PET/MR: Looking back for a moment
por: Nekolla, Stephan G.
Publicado: (2020)

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
por: Ceci, Francesco, et al.
Publicado: (2021)

A rare case of polyostotic fibrous dysplasia detected on (18)F-rhPSMA-7 PET/CT
por: Wang, Hui, et al.
Publicado: (2020)

Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on (18)F-rhPSMA-7.3 PET/CT in Patients with Prostate Cancer
por: Notohamiprodjo, Susan, et al.
Publicado: (2022)

An experimental phantom study of the effect of gadolinium-based MR contrast agents on PET attenuation coefficients and PET quantification in PET-MR imaging: application to cardiac studies
por: O’ Doherty, Jim, et al.
Publicado: (2017)

All that Glitters on PSMA is Not a Lesion: An Unusual Artifact on PSMA PET/CT
por: Dev, Indraja D., et al.
Publicado: (2021)

PSMA-PET for Lymph Node Detection in Recurrent Prostate Cancer: How do we use the Magic Bullet?
por: Maurer, Tobias, et al.
Publicado: (2017)

Do carotid MR surface coils affect PET quantification in PET/MR imaging?
por: Willemink, Martin J, et al.
Publicado: (2015)

Celiac ganglia: can they be misinterpreted on multimodal (68)Ga-PSMA-11 PET/MR?
por: Bialek, Ewa J., et al.
Publicado: (2019)

(68)Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
por: Rauscher, Isabel, et al.
Publicado: (2016)

New SPM8-based MRAC method for simultaneous PET/MR brain images: comparison with state-of-the-art non-rigid registration methods
por: Izquierdo-Garcia, David, et al.
Publicado: (2014)

[(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery
por: Schottelius, Margret, et al.
Publicado: (2015)

Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging study
por: Sonni, Ida, et al.
Publicado: (2023)

PET/MR imaging of sarcomas: effect of PET quantification by classification of tissue
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2014)

Automated synthesis of [(18)F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions
por: Wurzer, Alexander, et al.
Publicado: (2021)

Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center study
por: Murthy, Vishnu, et al.
Publicado: (2023)

A review of PET attenuation correction methods for PET-MR
por: Krokos, Georgios, et al.
Publicado: (2023)

PSMA-targeted imaging of prostate cancer: evolution of a success story
por: Maurer, Tobias, et al.
Publicado: (2017)

Impact of respiratory motion correction on lesion visibility and quantification in thoracic PET/MR imaging
por: Gratz, Marcel, et al.
Publicado: (2020)

Image artifacts from MR-based attenuation correction in dedicated PET/MR breast coil for PET/MR mammography
por: Cho, Ihnho, et al.
Publicado: (2015)

A hybrid method for generation of attenuation map for MR-based attenuation correction of PET data in prostate PET/MR imaging
por: Shandiz, Mehdi Shirin, et al.
Publicado: (2014)

Quantification and accuracy of clinical [11C]-PiB PET/MRI: the effect of MR-based attenuation correction
por: Law, Ian, et al.
Publicado: (2014)

The “question-mark” MR Anatomy of the Cervico-thoracic Ganglia Complex: Can it Help to Avoid Mistaking it for a Malignant Lesion on (68)Ga-PSMA-11 PET/MR?
por: Bialek, Ewa J., et al.
Publicado: (2019)

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer
por: Staniszewska, Magdalena, et al.
Publicado: (2021)

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
por: Spohn, Simon K. B., et al.
Publicado: (2023)

Cystinuria in Dogs and Cats: What Do We Know after Almost 200 Years?
por: Kovaříková, Simona, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5for1ccoc3q01op4l3k1v53ltv